Lensar (LNSR) Net Margin (2019 - 2026)
Lensar (LNSR) reported Net Margin of 0.26% for Q1 2026, up 19339.0% year-over-year from N/an in Q1 2025, and up 102.86% on a QoQ basis from 9.1% in Q4 2025.
Lensar (LNSR) has 8 years of Net Margin data on file, last reported at 0.26% in Q1 2026.
- Quarterly Net Margin rose 19339.0% year-over-year to 0.26% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 12.66% (up 9371.0% YoY) and the FY2025 annual result came in at 58.66%, up 966.0% from the prior year.
- Net Margin climbed to 0.26% in Q1 2026 per LNSR's latest filing, from 9.1% in the prior quarter.
- Across five years, Net Margin topped out at 14.63% in Q3 2023 and bottomed at 743.79% in Q1 2024.
- The 5-year median for Net Margin is 51.77% (2023), against an average of 96.03%.
- The widest annual swing landed in 2024, when Net Margin slumped 69202 bps; it then soared 55067 bps in 2025.
- Tracing LNSR's Net Margin over 5 years: stood at 24.34% in 2022, then sank by 54 bps to 37.39% in 2023, then sank by 237 bps to 126.18% in 2024, then soared by 93 bps to 9.1% in 2025, then soared by 103 bps to 0.26% in 2026.
- Per Business Quant, the three latest LNSR Net Margin figures stand at 0.26% (Q1 2026), 9.1% (Q4 2025), and 29.11% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.65% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.38% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 12.75% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.77% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.00% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 16.74% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 8.01% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 0.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.26% |
| Dec 31, 2025 | -9.10% |
| Sep 30, 2025 | -29.11% |
| Jun 30, 2025 | -14.35% |
| Mar 31, 2025 | -193.13% |
| Dec 31, 2024 | -126.18% |
| Sep 30, 2024 | -11.09% |
| Jun 30, 2024 | -84.64% |
| Mar 31, 2024 | -743.79% |
| Dec 31, 2023 | -37.39% |
| Sep 30, 2023 | 14.63% |
| Jun 30, 2023 | -72.87% |
| Mar 31, 2023 | -51.77% |
| Dec 31, 2022 | -24.34% |
| Sep 30, 2022 | -63.59% |
| Jun 30, 2022 | -102.05% |
| Mar 31, 2022 | -84.04% |
| Dec 31, 2021 | -26.44% |
| Sep 30, 2021 | -74.41% |
| Jun 30, 2021 | -64.32% |
| Mar 31, 2021 | -87.36% |
| Dec 31, 2020 | -63.20% |
| Sep 30, 2020 | -66.66% |
| Jun 30, 2020 | -89.10% |
| Mar 31, 2020 | -62.41% |
| Dec 31, 2019 | -21.22% |
| Sep 30, 2019 | -72.11% |